20Feb/13

Novartis Drug Zortress® Is First In Over A Decade Approved By FDA To Prevent … – Pharmaceutical Online (press release)

Novartis Drug Zortress® Is First In Over A Decade Approved By FDA To Prevent
Pharmaceutical Online (press release)
15, 2013 /PRNewswire/ — Novartis announced today that the US Food and Drug Administration (FDA) has approved Zortress® (everolimus) for the prophylaxis of organ rejection in adult patients receiving a liver transplant. of chronic renal failure was
Label Expansion for NVS’ Zortress – Analyst BlogNASDAQ

all 2 news articles »

20Feb/13

Mundipharma's bendamustine plus rituximab doubles PFS in non-Hodgkin … – The Pharma Letter

Mundipharma’s bendamustine plus rituximab doubles PFS in non-Hodgkin
The Pharma Letter
Results from the StiL NHL-1 study published in the Lancet today (February 20) show that a first-line treatment regimen of bendamustine (marketed under the trade name Levact by privately-held Swiss drugmaker Mundipharma) plus rituximab (B-R) doubles

and more »

20Feb/13

'It is like my own limb': First British person to undergo a hand transplant … – The Independent


The Independent

‘It is like my own limb’: First British person to undergo a hand transplant
The Independent
The first short-term success in human hand transplantation involved New Zealander Clint Hallam who lost his hand in an accident in prison. The hand was transplanted by a worldwide team of doctors in 1998 in Lyon, France. But in 2001 Mr Hallam, who

and more »